Xbiotech Inc (XBIT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,563 | -52,761 | -36,363 | -23,879 | -10,257 |
| Depreciation Amortization | 296 | 698 | 525 | 350 | 179 |
| Accounts payable and accrued liabilities | -1,835 | -981 | -2,074 | 1,536 | -2,348 |
| Other Working Capital | -2,365 | 475 | -1,416 | 2,417 | -1,686 |
| Other Operating Activity | 2,559 | 6,554 | 6,114 | 1,378 | 4,165 |
| Operating Cash Flow | $-11,908 | $-46,015 | $-33,214 | $-18,198 | $-9,947 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -607 | -13,914 | -11,946 | -8,774 | -2,917 |
| Investing Cash Flow | $-607 | $-13,914 | $-11,946 | $-8,774 | $-2,917 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 32,713 | 2,944 | 866 | 707 | N/A |
| Financing Cash Flow | $32,713 | $2,944 | $866 | $707 | $N/A |
| Exchange Rate Effect | 110 | 258 | 36 | 12 | 38 |
| Beginning Cash Position | 34,324 | 91,051 | 91,051 | 91,051 | 91,051 |
| End Cash Position | 54,632 | 34,324 | 46,793 | 64,798 | 78,225 |
| Net Cash Flow | $20,308 | $-56,727 | $-44,258 | $-26,253 | $-12,826 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,908 | -46,015 | -33,214 | -18,198 | -9,947 |
| Capital Expenditure | -607 | -13,914 | -11,946 | -8,774 | -2,917 |
| Free Cash Flow | -12,515 | -59,929 | -45,160 | -26,972 | -12,864 |